Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Berquist Ii

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPharmacology & Toxicology, College of Medicine
DivisionPharmacology Research
Address4104 Outpatient Circle
Mail Slot # 611
Little Rock AR 72205
ORCID ORCID Icon0000-0002-2696-4524 Additional info
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    1U01DA056240-01     (BERQUIST, MICHAEL D)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    5U01DA056240-02     (BERQUIST, MICHAEL D)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    5U01DA056240-03     (BERQUIST, MICHAEL D)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    U01DA056240-03     (BERQUIST, MICHAEL D)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Principal Investigator
    1U01DA056240     (STEVENS, MISTY W)Sep 30, 2022 - Jul 31, 2025
    NIH/Nat. Inst. on Drug Abuse - Pass Through: InterveXion Therapeutics, LLC
    IND-enabling studies of a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Parks BJ, Salazar P, Morrison L, McGraw MK, Gunnell M, Tobacyk J, Brents LK, Berquist MD. Limited bedding and nesting increases ethanol drinking in female rats. Pharmacol Biochem Behav. 2024 06; 239:173756. PMID: 38555037.
      View in: PubMed
    2. Tobacyk J, Parks BJ, Salazar P, Coward LU, Berquist MD, Gorman GS, Brents LK. Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. Drug Alcohol Depend. 2023 08 01; 249:110832. PMID: 37385117.
      View in: PubMed
    3. Niedzwiedz-Massey VM, Douglas JC, Rafferty T, Johnson JW, Holloway KN, Berquist MD, Kane CJM, Drew PD. Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation. Am J Drug Alcohol Abuse. 2023 05 04; 49(3):345-358. PMID: 36345683.
      View in: PubMed
    4. Berquist MD, Fantegrossi WE. Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats. Behav Pharmacol. 2021 08 01; 32(5):382-391. PMID: 33595958.
      View in: PubMed
    5. Findley DL, Berquist MD, Hambuchen MD. Methamphetamine-Induced Open Field Behavior and LD50 in Periplaneta americana Cockroaches (Blattodea: Blattidae). J Econ Entomol. 2021 02 09; 114(1):476-480. PMID: 33146384.
      View in: PubMed
    6. Berquist MD, McGill MR, Mazur A, Findley DL, Gorman G, Jones CB, Hambuchen MD. Effect of bile duct ligation-induced liver dysfunction on methamphetamine pharmacokinetics in male and female rats. Drug Alcohol Depend. 2020 10 01; 215:108190. PMID: 32736295.
      View in: PubMed
    7. Berquist MD, Leth-Petersen S, Kristensen JL, Fantegrossi WE. In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation. Drug Alcohol Depend. 2020 03 01; 208:107850. PMID: 31954950.
      View in: PubMed
    8. Berquist MD, Leth-Petersen S, Kristensen JL, Fantegrossi WE. Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization. Psychopharmacology (Berl). 2020 Feb; 237(2):431-442. PMID: 31729537.
      View in: PubMed
    9. Hyatt WS, Berquist MD, Chitre NM, Russell LN, Rice KC, Murnane KS, Fantegrossi WE. Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats. Behav Pharmacol. 2019 10; 30(7):555-565. PMID: 31211703.
      View in: PubMed
    10. Bullock TA, Berquist MD, Baker LE. Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine. Behav Pharmacol. 2019 10; 30(7):566-573. PMID: 31268871.
      View in: PubMed
    11. McClenahan SJ, Hambuchen MD, Simecka CM, Gunnell MG, Berquist MD, Owens SM. Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats. Drug Alcohol Depend. 2019 02 01; 195:140-147. PMID: 30634109.
      View in: PubMed
    12. Hambuchen MD, Berquist MD, Simecka CM, McGill MR, Gunnell MG, Hendrickson HP, Owens SM. Effect of Bile Duct Ligation-induced Liver Dysfunction on Methamphetamine Pharmacokinetics and Locomotor Activity in Rats. J Pharm Pharm Sci. 2019; 22(1):301-312. PMID: 31329536.
      View in: PubMed
    13. Fantegrossi WE, Wilson CD, Berquist MD. Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems. Drug Metab Rev. 2018 Feb; 50(1):65-73. PMID: 29385930.
      View in: PubMed
    14. Berquist MD, Fantegrossi WE. Discriminative Stimulus Effects of Psychostimulants. Curr Top Behav Neurosci. 2018; 39:29-49. PMID: 28341944.
      View in: PubMed
    15. Ford BM, Franks LN, Tai S, Fantegrossi WE, Stahl EL, Berquist MD, Cabanlong CV, Wilson CD, Penthala NR, Crooks PA, Prather PL. Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development. Pharmacol Res. 2017 Nov; 125(Pt B):161-177. PMID: 28838808.
      View in: PubMed
    16. Berquist MD, Hyatt WS, Bauer-Erickson J, Gannon BM, Norwood AP, Fantegrossi WE. Phencyclidine-like in?vivo effects of methoxetamine in mice and rats. Neuropharmacology. 2018 05 15; 134(Pt A):158-166. PMID: 28830759.
      View in: PubMed
    17. Berquist MD, Thompson NA, Baker LE. Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone. Psychopharmacology (Berl). 2017 Nov; 234(21):3271-3278. PMID: 28815279.
      View in: PubMed
    18. Hambuchen MD, Hendrickson HP, Gunnell MG, McClenahan SJ, Ewing LE, Gibson DM, Berquist MD, Owens SM. The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats. Drug Alcohol Depend. 2017 10 01; 179:347-354. PMID: 28844011.
      View in: PubMed
    19. Berquist MD, Baker LE. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats. Behav Pharmacol. 2017 08; 28(5):394-400. PMID: 28598863.
      View in: PubMed
    20. Berquist MD, Traxler HK, Mahler AM, Baker LE. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug Alcohol Depend. 2016 Jul 01; 164:128-134. PMID: 27181413.
      View in: PubMed
    21. Prus AJ, Mooney-Leber SM, Berquist MD, Pehrson AL, Porter NP, Porter JH. The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the a2 adrenoceptor antagonist yohimbine. Behav Pharmacol. 2015 Aug; 26(5):489-94. PMID: 26154437.
      View in: PubMed
    22. Berquist MD, Peet MM, Baker LE. Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice. Behav Pharmacol. 2015 Feb; 26(1-2):180-3. PMID: 25485643.
      View in: PubMed
    23. Berquist Ii MD, Mooney-Leber SM, Feifel D, Prus AJ. Assessment of attention in male and female Brattleboro rats using a self-paced five-choice serial reaction time task. Brain Res. 2013 Nov 06; 1537:174-9. PMID: 24055104.
      View in: PubMed
    Berquist Ii's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (120) concept(s)
    _
    Co-Authors Expand Description
    See all (8) people
    _
    Similar People Expand Description
    See all (35) people
    _
    Same Department Expand Description
    Search Department